Active	Status	Sponsor type	Region	Phase	Filter
22 Active 5 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shah, Kunal
NCT03926624: Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage	Recruiting	3	450	US	DFP-10917, Cytarabine, Azacitidine, Decitabine, Mitoxantrone, Etoposide, Fludarabine, Idarubicin, Venetoclax, Cladribine	Delta-Fly Pharma, Inc.	Leukemia, Myeloid, Acute	12/22	12/22
CADENZA, NCT03386513 / 2018-003210-40: Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN Jan 2024 - Dec 2024 : Top-line data from cohort 6 for 1L BPCDN	Active, not recruiting	1/2	179	Europe, US	IMGN632	AbbVie	Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm	09/23	12/26
MT-5111_001, NCT04029922: Study of MT-5111 in HER2-positive Solid Tumors	Terminated	1	50	US, RoW	MT-5111 (experimental study drug)	Molecular Templates, Inc.	HER2-positive Solid Cancers	02/23	04/23
NCT05293912: SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.	Recruiting	1	72	US	SG2501, Recombinant Anti-cluster of Differentiation 38(CD38)/47(CD47) Bispecific Antibody	Hangzhou Sumgen Biotech Co., Ltd.	Hematological Malignancy, Lymphoma	12/24	04/25
Sundborg, Michael
ACR-368-201, NCT05548296: A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma	Recruiting	1/2	390	US	ACR-368, prexasertib, Gemcitabine, OncoSignature	Acrivon Therapeutics, GOG Foundation	Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma	07/26	12/27
Boo, Sohyun
STEM, NCT04410146: The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma	Completed	N/A	310	Europe, US	SQUID Embolization, SQUID Embolization and Surgical Evacuation, Surgical Evacuation, Other: Medical Management	Balt USA, Balt Extrusion, Embo-Flüssigkeiten A.G., AXIOM Real Time Metrics	Subdural Hematoma, Chronic	02/24	05/24
WEB PAS, NCT04839705: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device	Recruiting	N/A	180	US	WEB	Microvention-Terumo, Inc.	Wide Neck Bifurcation Intracranial Aneurysms	12/25	12/29
Pfaendler, Krista S
GOG-3039, NCT04393285: Abemaciclib and Letrozole to Treat Endometrial Cancer	Active, not recruiting	2	53	US	Abemaciclib, Letrozole	Gynecologic Oncology Group, Eli Lilly and Company	Endometrial Cancer	12/24	12/25
Martinelli, Christina
No trials found
Caton, Michael T
No trials found
March, Lauren
No trials found